RE:RE:RE:RE:RE:RE:RE:RE:New here. Jus Grabbed a few sharesCurrent marketcap is $250M. $10M/$250M = 4%.
If Selby comes up short on a partnership by Q1 and needs to raise on the open market, I think there would be some well-deserved skepticism that would drive the marketcap down and increase the dilutive effect. I also said $30M, so 4% x ($30M/$10M) = 12% before accounting for the presumed drop in share price.
50% was a bit of hyperbole meant to harken back to Dumont. Maybe this time is different.
SimplyRunRig wrote: If they were to sell shares to pay off the $10M, at least it would require only about a 3% dilution rather than 30 or 50% of the company.
N3tPr0phet wrote:
It was somewhat tongue-in-chick but Auramet presently holds a $10M facility loan against CNC, the relatively unfavourable terms of which were meant to tide the company over while they made a deal with a strategic partner.
This strategic partner was originally represented as being announced before Christmas, which turned into Q1, by which the facility loan is slated to mature.
Meanwhile, Dumont is shovel ready and still hasn't sold, after Mark Selby pissed it away for nothing to an Auramet-equivalent. If CNC is still partner-less come the end of March, it's going to be really bad optics.
Should be fine though. There's an entire cheerleading contingent here who know that this stock will easily 10-bag and Mark Selby is literally fighting off assassins who want in on CNC, so it's probably a smart play.